Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Maria Gomez

Maria Gomez

Professor

Maria Gomez

Glucose-Dependent Insulinotropic Polypeptide (GIP) Stimulates Osteopontin Expression in the Vasculature via Endothelin-1 and CREB.

Author

  • Lisa Berglund
  • Valeriya Lyssenko
  • Claes Ladenvall
  • Olga Kotova
  • Andreas Edsfeldt
  • Kasper Pilgaard
  • Sami Alkayyali
  • Charlotte Brøns
  • Carol Forsblom
  • Anna Jonsson
  • Anna Zetterqvist
  • Mihaela Nitulescu
  • Christian Ruiz McDavitt
  • Pontus Dunér
  • Alena Stancáková
  • Johanna Kuusisto
  • Emma Ahlqvist
  • Maria Lajer
  • Lise Tarnow
  • Sten Madsbad
  • Peter Rossing
  • Timothy J Kieffer
  • Olle Melander
  • Marju Orho-Melander
  • Peter Nilsson
  • Per-Henrik Groop
  • Allan Vaag
  • Bengt Lindblad
  • Anders Gottsäter
  • Markku Laakso
  • Isabel Goncalves
  • Leif Groop
  • Maria Gomez

Summary, in English

Glucose-dependent insulinotropic polypeptide (GIP) is an incretin hormone with extrapancreatic effects beyond glycemic control. Here we demonstrate unexpected effects of GIP signaling in the vasculature. GIP induces the expression of the pro-atherogenic cytokine osteopontin (OPN) in mouse arteries, via local release of endothelin-1 (ET-1) and activation of cAMP response element binding protein (CREB). Infusion of GIP increases plasma OPN levels in healthy individuals. Plasma ET-1 and OPN levels are positively correlated in patients with critical limb ischemia. Fasting GIP levels are higher in individuals with a history of cardiovascular disease (myocardial infarction, stroke) when compared to controls. GIP receptor (GIPR) and OPN mRNA levels are higher in carotid endarterectomies from patients with symptoms (stroke, transient ischemic attacks, amaurosis fugax) than in asymptomatic patients; and expression associates to parameters characteristic of unstable and inflammatory plaques (increased lipid accumulation, macrophage infiltration and reduced smooth muscle cell content). While GIPR expression is predominantly endothelial in healthy arteries from human, mouse, rat and pig; remarkable up-regulation is observed in endothelial and smooth muscle cells upon culture conditions yielding a "vascular disease-like" phenotype. Moreover, a common variant rs10423928 in the GIPR gene associated with increased risk of stroke in type 2 diabetes patients.

Department/s

  • EXODIAB: Excellence in Diabetes Research in Sweden
  • EpiHealth: Epidemiology for Health
  • Diabetic Complications
  • Genomics, Diabetes and Endocrinology
  • Cardiovascular Research - Immunity and Atherosclerosis
  • Cardiovascular Research - Hypertension
  • Diabetes - Cardiovascular Disease
  • Internal Medicine - Epidemiology
  • Vascular Diseases - Clinical Research

Publishing year

2016

Language

English

Pages

239-254

Publication/Series

Diabetes

Volume

65

Issue

1

Document type

Journal article

Publisher

American Diabetes Association Inc.

Topic

  • Endocrinology and Diabetes

Status

Published

Research group

  • Diabetic Complications
  • Genomics, Diabetes and Endocrinology
  • Cardiovascular Research - Immunity and Atherosclerosis
  • Cardiovascular Research - Hypertension
  • Diabetes - Cardiovascular Disease
  • Internal Medicine - Epidemiology
  • Vascular Diseases - Clinical Research

ISBN/ISSN/Other

  • ISSN: 1939-327X